Insigma Technology (SHA:600797) said its joint-stock company completed listing on the Hong Kong Stock Exchange, according to a Shanghai Stock Exchange disclosure on Friday.
Hangzhou Jiuyuan Gene Engineering (HKG:2566) was listed on Nov. 28, offering 45.4 million shares for HK$12.42 apiece.
After the completion of the listing, the Chinese information technology services provider, through subsidiary Netnew Ventures, holds 24.5 million shares or 9.99% of Jiuyuan Gene Engineering. Netnew Ventures' lock-up period for Jiuyuan Gene shares is 12 months after the listing.
Insigma Technology's shares rose more than 2%, while Jiuyuan Gene Engineering's shares rose more than 4% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.